Press release
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2017
The Report Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report Glial Cell Line Derived Neurotrophic Factor - Pipeline Review, H2 2017, outlays comprehensive information on the Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Glial -derived neurotrophic factor is a member of the cysteine-knot superfamily of growth factors. It promotes the survival and differentiation of dopaminergic neurons and was able to prevent apoptosis of motor neurons. The mature form of the protein is a ligand for the product of the RET (rearranged during transfection) protooncogene. The molecules developed by companies in Phase II and Preclinical stages are 2 and 4 respectively. Similarly, the universities portfolio in Phase II and Discovery stages comprises 1 and 1 molecules, respectively. Report covers products from therapy areas Central Nervous System and Ophthalmology which include indications Amyotrophic Lateral Sclerosis, Parkinson's Disease, Brain Ischemia, Neurodegenerative Diseases and Retinal Degeneration.
View Report @ https://www.marketresearchreports.biz/reports/1324458/glial-cell-line-derived-neurotrophic-factor-astrocyte-derived-trophic-factor-or-gdnf-pipeline-review-h2-2017-market-research-reports
Furthermore, this report also reviews key players involved in Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Scope
- The report provides a snapshot of the global therapeutic landscape for Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)
- The report reviews Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics and enlists all their major and minor projects
- The report assesses Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics
Get Sample Copy Of This Report @
https://www.marketresearchreports.biz/sample/sample/1324458
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2017 here
News-ID: 719524 • Views: …
More Releases from marketresearchreports.biz/

Asia-Pacific Automotive High-performance Air Filter Market Analysis and Forecast …
"The Report Asia-Pacific Automotive High-performance Air Filter Market Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
In this report, the Asia-Pacific Automotive High-performance Air Filter market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split…

EMEA (Europe, Middle East and Africa) LED Light Bulbs Market 2017 Forecast to 20 …
"The Report EMEA (Europe, Middle East and Africa) LED Light Bulbs Market 2017 Forecast to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
"LED Light Bulbs [LED Lighting] is a kind semiconductor light-emitting solid device, which can convert the energy from an electric current into light.
LED Light Bulbs Principles:
Terminal voltages of PN junctions form certain barrier potentials, and when the forward…

EMEA (Europe, Middle East and Africa) Icebreakers Market 2017 Forecast to 2022
"The Report EMEA (Europe, Middle East and Africa) Icebreakers Market 2017 Forecast to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
An ice-breaker is a large ship which sails through frozen waters, breaking the ice as it goes, in order to create a passage for other ships.
Scope of the Report:
This report focuses on the Icebreakers in EMEA market, covering Europe, Middle…

EMEA Colposcope Market Size, Share and Forecast to 2022
"The Report EMEA (Europe, Middle East and Africa) Colposcope Market 2017 Forecast to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Colposcope is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through…
More Releases for Derived
Animal Derived Ingredients Market Analysis and Opportunities
Animal-Derived Ingredients Market is valued at $100 billion in 2024 and is projected to reach $150 billion by 2034, growing at a 5.5% CAGR.
On February 26, 2025, Exactitude Consultancy., Ltd. released a research report titled "Animal Derived Ingredients Market "evaluation provides information on the major business trends that will impact the market's growth between 2025 and 2034. It provides information on the fundamental business strategies used in this market. The…
Gasogel" : "Fast Relief, Naturally Derived
Dankuni West Bengal, 11/07/24 - Kent Homoeo Pharmacy & Laboratory, a leading name in homeopathic healthcare, is thrilled to announce that its product, "Gasogel", has achieved bestselling status. "Gasogel", an effective antacid and antiflatulent suspension, has become a favourite among consumers for its natural and efficient relief from digestive discomfort.
"Gasogel" is specially formulated to address issues such as acidity, gas, and bloating, offering a natural solution for digestive health. Each…
Tire Derived Fuel Market
According to the latest research report published by Market Data Forecast, the global hemp oil market was valued at US$ 114 million in 2023 and is predicted to reach a valuation of US$ 794 million by 2029, and it is predicted to register a CAGR of 38.2% from 2024-2029.
Hemp is steadily prevalent as a treatment for various ailments. Such as stress and skin problems. Also, it has qualities that lower…
Global Plasma Derived Therapies Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Plasma Derived Therapies Market is expected to grow at a CAGR of 7.5% from 2023 to 2028.
The market for plasma-derived therapies is expected to be driven by high prevalence of chronic blood diseases, advancements in plasma collection & fractionation technologies, and rising demand for safe, effective and minimally invasive treatment procedures.
Browse 147 Market Data Tables and…
Pine Derived Chemicals Market Industry Analysis - Pine Derived Chemicals Market …
Acumen Research and Consulting has recently published a research report on the Pine Derived Chemicals Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Pine Derived Chemicals Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030.
The research study on the Pine Derived Chemicals Market…
Pine Derived Chemicals Market Industry Analysis - Pine Derived Chemicals Market …
The Global Pine Derived Chemicals Market Size accounted for USD 5.4 Billion in 2021 and is projected to occupy a market size of USD 8.1 Billion by 2030 growing at a CAGR of 4.7% from 2022 to 2030.
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1172
Pine Derived Chemicals Market Dynamics
The market for pine-derived chemicals promotes the use of renewable energy sources. It also supports policies involving biomass or inexhaustible resources. Actions are…